SCHEMBL18403954

SCHEMBL18403954

CCc1nc(Cl)c2c(n1)C=CCCCS2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9385093 0.72 PDE4B (0.31) —
SCHEMBL3111399 0.55 — —
SCHEMBL5234964 0.55 KMT2A (0.37) —
SCHEMBL1189048 0.55 PDE4B (0.30) —
SCHEMBL31044813 0.54 SELE (0.58) —
SCHEMBL20668056 0.54 SELE (0.39) —
SCHEMBL31044972 0.54 SELE (0.39) —
SCHEMBL21477549 0.54 — —
SCHEMBL20668034 0.53 SELE (0.38) —
SCHEMBL21477571 0.53 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585470-B1 NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY HANMI SCIENCE CO LTD (KR) 2017-01-25 — — EP disclosed
Send feedback